Abstract.
We IT HAD BEEN well accepted that body size is one of the major determinants of actual bone mineral density [1-3]. Possible reasons for the correlation between ponderosity and bone mineral density are the following:(1) peak bone mass is greater in obese people than in slender people,(2) body size and bone size are greater in obese people than in slender people,(3) mechanical stress acting on bone is greater in obese people than in slender people,(4) obese people have some metabolic advantages in maintaining bone mineral content. Bell et al.[4] were the first to report that hormonal factors such as secondary hyperparathyroidism associated with a higher serum level of active vitamin D may account for the higher BMD in young obese people than in slender people. In general, the serum level of PTH increases with age [5,. 6], and the production of 1, 25-dihydroxyvitamin D (1,25-(OH)2D) in kidney decreases with age [7, 8] . Despite the abnormal calcium regulating mechanisms in the elderly, the higher bone mineral density still exists in elderly obese people [2] .
The aim of the present study was therefore to clarify what mechanisms contribute to the maintenance of bone mineral density in obese elderly females. Significant differences in RMD between groups 1 and 2, and groups 1 and 3 (p<0.01 in Student's t-test) were found (Fig. 1 ).
Calcium metabolism There were no intergroup differences with regard to serum levels of Ca, P, PTH and vitamin D metabolites.
The fasting urinary Ca/Cr ratio tended to decrease with the increase in BMI. The serum CT level increased as the BMI increased (p<0.01 in ANOVA and p<0.01 in Student's t-test between groups 1 and 3)( Table  2) . Vertebral X-ray pictures were taken in all subjects to determine the presence or absence of vertebral fracture. The measurement of the P/A ratio for each vertebral body was performed by the doctor (M.S.) without specifying the name of the subject. The number of subjects with vertebral fracture and the total number of subjects in each class of ponderosity are shown in the Figure. The incidence of vertebral fracture was found to vary according to the BMI (p<0.01 in f-test). The radial mineral density in each category of BMI is also shown. There was a significant increase in RMD in accordance with the increase in the BMI (p<0.01 in ANOVA and *p<0.01 between slender and normal groups, and slender and obese groups in Student's t-test).
Steroid hormones
one were increased as the BMI increased (p<0.05-0.01 in ANOVA). However, there was no intergroup difference with regard to the other steroid hormones such as estrogens, glucocorticoid and mineral corticoid. The significant differences in serum levels of androgens in the 3 groups were mainly responsible for the differences between groups 1 and 2, because the significant differences in androgen levels were observed only between groups 1 and 2 but not between groups 2 and 3. However, the serum testosterone level of group 1 was significantly lower than that of group 3 (p<0.05 in Student's t-test). There was no signilevel in group 1 and that in 2.
Coefficients of correlation between RMD and serum levels of hormones Table 4 shows the coefficients of correlation between body size, age and serum levels of hormones, and RMD. Age, body size, calcitonin and androgens levels were highly correlated with RMD.
Discussion
One of the facts demonstrated in the present study is that serum levels of PTH and 1,25-(OH)2D do not change in elderly women regardless of ponderosity. This fact largely differed from the results reported by Bell et al. [4] , in young subjects. A possible explanation for this discrepan- cy is the difference in the degree of obesity. In fact, our obese subjects in the present study were mostly people who belonged to the overweight range (maximum body weight and BMI were 78 Kg and 35 Kg/m2, respectively), while the subjects reported by Bell et al. were from the overweight to the morbidly obese. Therefore, it is possible that secondary hyperparathyroidism with higher production of 1,25-(OH)2-D can be observed only in morbid obesity.
In the present study, calcitonin (CT) was the only calcium regulating hormone that was signiknown to be a potent inhibitor of bone resorption [15] , so the difference in the serum level of CT may partly explain the intergroup difference in bone mineral density found among the three groups.
In the present study, we measured serum levels of steroid hormones in relation to the ponderosity of the subjects. It has been widely accepted that the serum level of estrogens plays an important role in the diminishment of bone mineral density in females around menopause [16, 17] . However, it is still not clear whether estrogens play an important role in elderly females in relation to their bone mineral density. Serum estrogens in women after menopause derive from the peripheral conversion of androgens produced by the adrenal glands. This process of converting androgens to estrogens is catalyzed by aromatase which is located in muscles and in fat tissues [18] . Therefore, it is possible that obese elderly women have higher serum levels of estrogens because of the greater amount of the converting enzyme [19] which they have. However, the serum levels of estrogens did not differ in accordance with their ponderosity. Furthermore, there was no significant correlation between the serum estrogen levels and RMD. The fact that there were no significant intergroup differences in the serum levels of gonadotropins (LH and FSH) was consistent with the absence of a difference in the estrogen levels. In spite of these negative findings, we think that estrogens may contribute somewhat to the maintenance of bone mineral density in elderly females, since the obese group had fewer years after menopause, and a lower fracture incidence and larger RMD than those in slender subjects. This fact may mean that the serum levels of estrogens are more important in the menopause than in the elderly phase. In addition, we have to pay attention to the assay sensitivity in estradiol radioimmunoassay, because 15% (14 out of 93 cases) of the present subjects had less than 10 pg/ml estradiol in the serum which was the minimal detectable limit in the present assay. Nine cases in whom the serum estradiol level could not be measured belonged to group 1. Thus, it is possible that the serum level of estradiol may be much lower than in the present results in group 1. We cannot therefore imply that estrogens play no significant role in the maintenance of BMD in elderly females.
On the other hand, the present results clearly demonstrated the signfiicant difference in serum levels of androgens in a BMI-related manner. Furthermore, these androgen levels significantly correlated with RMD. These results are in good agreement with previous reports indicating that serum androgens are more greatly decreased in patients with osteoporosis than in age-matched controls [20, 21] . Recently, it has been reported that androgens promote osteoblastic proliferation [22] . Thus, androgens may play an important role in bone mineral metabolism in elderly females.
In conclusion, we found that even in elderly females, body size is a determinant factor in bone mineral density. The possible contributing factors for higher bone mineral density in obese subjects might include late menopause and higher serum levels of CT as well as androgens. women. An analysis of some anthropometric background factors. Age and Aging 13: 6-13.
